Haven't either Dr. Kaufamn or Dr. Kogelnik said something publicly about how they have not had the same level of success with Rituximab as the Norwegians have. ??? I am pretty sure I have read this statement somewhere.
http://forums.phoenixrising.me/index.php?threads/rituximab-in-the-usa-dr-kogelnik.14024/
Look at the first post. Too bad the blog isn't working any longer. I think he has said that he is seeing the same results as the Norwegians, but I can't find it...
@Gingergrrl, could it be that your insurance would deny you treatment in the US because of the cost, but give you the funds to have the treatment done in Europe if they save 20 grand??
Even though, they are not doing a proper study, so impossible how to interpret results. Not sure if they only accept patients that fulfil the Canada criteria. I think all we have is the two studies from Norway. Around 2/3. Then create a safety margin. Multi-centre trials tend to show longer response rates. Say 50% respond. While 50% not. I think Fluge and Mella has said they are pretty certain that that is what we're looking at. You'll get the results with the final results first half 2018. The question is whether one want to wait or not. For those living in the US I would try to find out if medical insurance would cover it if phase 3 trial comes out positive. I have no idea how you're system works on drugs that are non FDA approved. If the study is positive, and you'll still have to pay all out of pocket then I would probably consider going to Norway now and try. At least if one is in OK shape to do it, both physically and financially. On the other hand, if life is okay, you're able to have a decent life. Taking care of your own, have some fun, having enough energy to be in a relationship and so on, I think I would wait.
Just some late night thoughts from the neighbour of Sweden (I too survived last weekend!)